This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2025 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Richard Wilson
Vice President, North America, Rare Disease Franchise Head at Kyowa Kirin North America
Speaker

Profile

Mr. Wilson brings more than 25 years of diversified experience in Sales, Global/US Marketing, Alliance Management, Business Development & Licensing, and General Management.

He previously served as Vice President and Head US Endocrine Franchise at Takeda, where he had full P&L responsibility for the US Endocrine Franchise and general management for all cross-functional activities (Marketing, Sales, Medical, Market Access, Patient Services). He also represented US interests to ensure Global strategic alignment (Global Project Team) and with LCM activities including Business Development & Licensing.

He worked for 3 years at Shire and more than 11 years at Novartis, where after rising through the global ranks, he ultimately served as Executive Director of Global Strategic Alliances and as Business Development and Licensing Executive Director.

He earned his Master of Business Administration from Cornell Johnson Graduate School of Management and his Bachelor of Science in Chemistry from the University of Exeter.

You can learn more about Kyowa Kirin North America at: kkna.kyowakirin.com.

Agenda Sessions

  • Manufacturer Considerations for Building a Strategic Commercialization Plan

    11:00am